Completed PHASE4 INTERVENTIONAL 2-arm NCT01941888

Propofol TCI Administered by Gastroenterologists During Endoscopy: a Randomized Double Blind Controlled Study (PropTCI/2012)

Phase IV Study of Propofol TCI (Target Controlled Infusion)Administered by Gastroenterologists During Endoscopy in Moderate Sedation: a Randomized Double Blind Controlled Study

Sponsor: Ospedale San Raffaele

Conditions Gastrointestinal Endoscopy Moderate Sedation Propofol Target Controlled Infusion

Interventions Midazolam Propofol Target Controlled Infusion

Updated 5 times since 2017 Last updated: Sep 10, 2013 Started: May 31, 2012 Primary completion: Mar 31, 2013 Completion: Mar 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Gastrointestinal Endoscopy and Moderate Sedation and is currently completed. Ospedale San Raffaele leads this study, which shows 5 recorded versions since 2012 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

May 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ospedale San Raffaele

Data source: Ospedale San Raffaele

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Milan, Italy